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Abstract 
Three polyether-ester triblock diols, with various molecular weights, were 
synthesized from ε-caprolactone and polyethylene glycol and used, with diisocyanates, 
as soft segments for the preparation of polyurethane acrylate oligomers. The 
polyurethane acrylates were used to generate cross-linked polyurethane films via UV 
initiated polymerization with and without cargo incorporation. Degradation 
experiment indicated that in PBS/H2O2/CoCl2 the membranes degraded rapidly 
compared to PBS alone or with lipase. The polyurethane membrane loaded with the 
antibiotic tetracycline, demonstrated prolonged release over 200 h, suggesting that the 
polymers could be used as an implant coating for controlled drug release. 
 
Keywords：Poly(ether-ester)；Polyurethane acrylates；Biodegradable；Controlled drug 
release; Tetracycline 
 
1. Introduction 
Microspheres of polycaprolactone (PCL) and its copolymers are widely used in 
biomedical applications, especially in drug delivery, due to their excellent 
biodegradability, biocompatibility and drug releasing ability [1-2]. Many different 
types of PCL copolymers can be made including PCL homopolymers, PCL based 
amphiphilic copolymers, and polymers where PCL is used as a soft segment of a 
polyurethane. PCL homopolymers are a family of commonly used drug carriers, 
typically synthesized via ring-opening polymerization of ε-caprolactone (ε-CL) 
catalyzed by various initiators [3], however PCL homopolymers degrade very slowly 
under aqueous conditions due to their hydrophobicity which offers poor water 
permeation abilities. Modification of PCL to improve its water affinity and 
degradation rate can be achieved using PEG segments [4]. PCL based amphiphilic 
block copolymers typically display better water compatibilities than PCL 
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homopolymers and can be prepared by conjugation with hydrophilic materials such as 
polyethylene glycol or polyacrylates [5]. These PCL amphiphilic copolymers are 
versatile building blocks that can be used to make a variety of multi-functional 
polymeric materials which can self-assemble into nano structures such as vesicles and 
micelles [6,7] as well as microspheres [8]. Upon incorporation of these functional 
groups polymers have been shown to be responsive to environmental stimuli such as 
temperature [9,10], pH [11,12], and reduction [13,14]. They can form matrices such 
as films, fibers and scaffolds for drug release [15] as well as injectable or oral vessels 
for controlled targeted drug delivery [16]. PCL polymers have also been used as soft 
segments in polyurethanes that have been used in drug delivery due to their non-toxic 
degradation products. Thus ophylline was encapsulated, for controlled drug release, 
within polyurethane microspheres composed of PCL and starch as the soft segments, 
with 4,4’-diphenylmethane diisocyanate (MDI) and 1,4-butanediol as the hard 
segments [17] with drug release dependent on the dissolution and diffusion of the 
drug as well as degradation of the polymer. 
 
Biomaterials play an important role in many medical devices including as coatings for 
urinary catheters, or other implant devices, where they need to display both 
biocompatibility and anti-bacterial abilities. To generate anti-bacterial capability 
polymeric medical devices have incorporated many features, including metal ions (e.g. 
Ag+), quaternary ammonium salts, antibiotics or PEG. Antibacterial 
polyurethane-based materials have been used as coatings for implant devices to 
increase biocompatibility and reduce inflammation. Basak [18,19] developed porous 
polyurethane films (using poly(ether-ester) diols obtained by reacting PEG400 with 
lactate and 2,4-toluene diisocyanate (TDI)) loaded with antibiotics (such as rifampicin, 
gentamicin and ciprofloxacin). The primarily release mechanism for the hydrophilic 
drugs being mainly related to diffusion while the release of lipophilic drugs was 
controlled mainly by polymer degradation. 
 
Mândru [20] synthesized a poly(ester-ether urethane) using poly(butylene adipate) 
diol and PEG as soft segments and MDI together with 1,4-butanediol (BDO) as hard 
segments, from which the antibiotic rifampicin was released in a controlled manner 
depending on the molar concentration of urethane groups in the polymer chains as 
well as the surface morphology of the polyurethane membranes. 
 
Here polyurethane acrylates that contained as a soft segment a block copolymer of 
polycaprolactone-poly(ethylene glycol)-polycaprolactone (PCL-PEG-PCL) were 
investigated as a biodegradable drug release vehicle. Polymers of differing 
composition were synthesized by ring-opening polymerization of ε-caprolactone in 
the presence of PEG400 which was subsequently reacted with diisocyanates followed 
by hydroxylethyl methacrylates to give polyurethane acrylates (PUAs). By UV-curing 
the PUAs were polymerized to form cross-linked elastomers. Their properties and 
drug release profile from the cross-linked PUAs were studied. 
 
2.Materials and Methods 
2.1. Materials  
1,6-Hexamethylene diisocyanate (HDI), isophorone diisocyanate (IPDI) and 
hydroxylethyl methylacrylate (HEMA) were purchased from Aladdin. ε-Caprolactone, 
was bought from Heowns Biochem Technologies LLC，and dried with CaH2 for 24 h 
at room temperature and then distilled under vacuum before use. A solution of 
organo-bismuth (20 %) was purchased from Xianju Fusheng Compound Material Co. 
Ltd. PEG (Mw400), from Shanghai Ling feng Reagent Co. Ltd., was dried at 100oC 
under vacuum for 2 h to remove residual water before use. Stannous octoate (Sn(Oct)2) 
and 1-hydroxycyclohexyphenylketone (PI 184) were obtained from Sinopharm 
Chemical Reagent Co. Ltd. Toluene was dried by stirring with CaH2 for 24 h before 
distillation and stored over 4 Å molecular sieves. The broad-spectrum antibiotic 
tetracycline (as the drug model) was purchased from Energy Chemical. All reagents 
were used as received unless mentioned otherwise. The UV lamp (model SB-100P/FA 
(100 w)) was from Westbury, USA. 
	Scheme 1: Synthesis of the polyurethane acrylate oligomers 
 
2.2 Methods 
2.2.1 Synthesis of polycaprolactone-poly(ethylene glycol)-polycaprolactone block 
copolymer (PdiolX) 
The triblock copolymer diols (Scheme 1 and Fig. 1) were synthesized using PEG 
(Mw400, 5 g) to initiate the polymerization of ε-caprolactone (20 g) with Sn(Oct)2 (0.3 
wt%) as a catalyst in toluene (1 mL) at 130 oC for 24 h under stirring to obtain the 
triblock copolymers. To synthesize the copolymer diols with various molecular 
weights, the following molar ratios of PEG400 and ε-caprolactone were used (1/5, 
1/14, 1/23 respectively) [21]. These ratios were used to control molecular of the soft 
segment (polymer diol) keeping it between 1000-3000 Da. 
The products obtained were precipitated with excess cold hexane and ethyl ether 
respectively followed with centrifugation (1500 rpm) and drying in a vacuum oven at 
50 oC for 24 h. The PCL-PEG400-PCL triblock copolymers are abbreviated as PdiolX 
where X represent the molecular weight of the triblock poly(ether ester). 
 
2.2.2 Synthesis of PUAs 
Polymers were synthesized using a two-step polymerization approach with a 2:1:2 
ratio of diisocyanate (HDI or IPDI), PdiolX triblock copolymer and HEMA (as a 
capping agent) [22]. PdiolX (0.02 mol), toluene (4 mL), diisocyanate (0.04 mol) and 
Sn(Oct)2  (0.05 g0.3 %wt) were added into the reactor and the reaction was carried 
out at 80 oC under dry nitrogen atmosphere for 3 h to obtain the isocyanate terminated 
polyether-ester diols. The solution was cooled to room temperature and HEMA (0.04 
mol) was added dropwise under stirring. The reaction was heated to 80 oC under 
nitrogen and stopped (> 4 h) when the NCO groups of the polyurethane (at 2270 cm−1) 
had disappeared as monitored by FTIR. The PUAs were precipitated following the 
addition of excess ethyl ether and collected by centrifugation (1500 rpm). The 
products were dried in a vacuum oven at 40 oC for 24 h to eliminate residual solvent. 
 
2.2.3 Preparation of cross-linked PUA films 
3 g of PUA were dissolved in DMF (1.5 mL, 200 %wt/v), followed by the addition of 
photo initiator (1 wt%，PI 184) and the solution stirred until homogeneous. The 
mixture was poured into glass molds previously coated with 1H, 1H, 2H, 
2H-perfluorooctyl dimethyl chlorosilane (10 cm × 6 cm × 0.05 cm). The solution was 
exposed to UV light for 20 min and the films were placed in an oven at 50 oC for 4 h. 
The films were peeled off and washed in acetone for 12 h and then dried in a vacuum 
oven at 40 oC for 24 h. The films were cut into 10 mm × 10 mm samples and were 
approximately 0.05 cm (0.5 mm) thick. 
2.2.4 Drug trapping in the cross-linked PUA films 
The cross-linked PUA films (10 mm × 10 mm × 0.5 mm) were immersed into 8 mL 
of a THF solution of tetracycline (1 mg/mL) for 12 h. The swollen films were wiped 
with filter paper and dried in a vacuum oven at 40 oC for 6 h. The amount of 
tetracycline loaded in the polymer films were determined by soaking the films in THF 
(8 mL) for unloading under sonication for 1 h before the THF with the drug 
quantified/analyzed by UV/Vis spectrometery and compared to a standard 
concentration curve of tetracycline in THF.  
 
2.3 Polymer characterization 
1H NMR spectra were recorded on a Bruker Avance NMR (400 MHz) with CDCl3 as 
the solvent and tetramethylsilane (TMS) as the internal standard. Number average 
molecular weight (Mn), weight average molecular weights (Mw) and polydispersity 
index (PDI) of the triblock copolymer diols and PUAs were determined using gel 
permeation chromatography (GPC) (Waters Alliance 515). THF was used as the 
eluent at a flow rate of 1.0 ml/min at 20 °C, with molecular weights calibrated using 
polystyrene standards. 
Differential scanning calorimetry (DSC) was performed using a Perkin-Elmer DSC 
800 under nitrogen at a constant heating rate of 10 °C/min. Samples were first heated 
from room temperature to 120 °C and held isothermally for 5min, followed by 
cooling from 120 to -75 °C and maintained at this temperature for 10min. Finally, the 
second heating was carried out from -75 to 120 °C. Sample weight for all 
measurements was in the range of 5-10 mg. X-ray diffraction analysis (XRD) was 
used to evaluate the crystallinity of the cross-linked PUA films with a STADI P 
diffractometer (STOE, Germany). The X-ray source was Cu/Kα radiation, powered at 
40 kV and100 mA with a radiation wavelength of 1.542 Å. The scattering angle (2θ) 
ranges from 5 to 60° and was scanned at 2°/min. Dynamic mechanical analysis 
(DMA8000 ) was used to characterize the storage modulus and dissipation factor in 
corresponding to temperature. It was carried out in a tension mode at a single 
frequency of 1Hz, 0.04% strain and a heating rate of 4 oC /min in the range of -100 to 
150 oC. 
Contact angle measurements were performed using a JC2000D1 (Xiamen Maikailun 
Co., Ltd. China) equipped with a camera for imaging the test drops on the sample 
surfaces. The images were subsequently analyzed and calculated with the supplied 
software. Water was used as solvent for contact angle analysis at room temperature 
(~20 oC). Static and dynamic contact angles were measured with test interval of 5 min 
for the latter. For each sample the result was the average of four measurements. The 
swelling of a sample was measured by weighing the weight change of membrane(10 
mm × 10 mm × 0.5 mm) before and after soaking in distilled water for 6, 24, 48 
and 72 h, and in THF solution for 6 and 24 h in an incubator at 37oC with a shaking 
speed of 60 rpm. At periodic intervals, the sample was removed from water or THF 
and wiped with filter paper to remove solvent from the surface of the film before 
weighing. Swelling of the samples was calculated by using following formula (1): 
                (1)	
Where, Wa and Wb are the mass of the sample after and before soaking in water or 
THF, respectively. The result of swelling was reported as an average of four 
replicates. 
 
2.4 In vitro degradation 
The degradation properties of the cross-linked PUA films were analyzed in vitro by 
measuring the weight loss over time in specific degradation solutions. Hydrolytic 
degradation was carried out in phosphate buffered saline (PBS) (0.01 M PBS with 
0.02 % NaN3, pH 7.40), enzymatic degradation was carried out in PBS buffer solution 
with 1 mg/mL lipase. Oxidative degradation was carried out in PBS buffer solution 
with H2O2 (20 wt%) and CoCl2 (0.01 M). H2O2/CoCl2 oxidative solution can 
b
b
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effectively generate hydroxyl radicals and hydroperoxy radicals which attack the 
polyether or polyester to cause degradation [23-24]. Each sample was placed into an 
individual vial containing 8 mL of the degradation solution, and then incubated at 37 
oC with constant shaking (60 rpm). At one-week intervals, the sample was cleaned 
with deionized water for 6 h and dried in a vacuum oven at 50 oC for 24 h before 
being weighed. The weight loss was calculated using the following equation (2)： 
                    (2)	
Where, Wb and Wa are the weights of the sample before and after degradation. The 
result for weight loss was reported as an average of four replicates. 
 
2.5 Drug release and analysis 
The stock drug solution was prepared by dissolving 4 mg tetracycline in 20 mL PBS 
or THF and used to prepare diluted solutions at 0.1, 0.05, 0.025, 0.01, 0.005 and 0.001 
mg/mL. The absorbance of tetracycline was measured at 361 nm and the standard 
calibration curve was obtained by plotting the absorbance against the corresponding 
concentration of tetracycline solution (see Support Information). The soaked film was 
dried in a vacuum oven at 40 °C for 24 h. 
To analyze the drug release profiles, the drug-loaded polymer films were placed in a 
dialysis bag and placed in a glass vial containing 8 mL of PBS. Periodically, the PBS 
solution was removed for absorbance measurement. Antibacterial assays (using E. 
coli) were performed to test the antibacterial properties of the polymer films with and 
without loaded drug.  
E. coli were cultured for 12 h in a liquid medium (NaCl 5 g, beef extract 5 g and 
tryptone 10 g and water 1 L) at 37 oC. 100 µL of the cultured bacterial solution was 
inoculated on each sterilized agar plate. The cross-linked PUA films with and without 
loaded drug were placed on top of the agar plate and incubated at 37 oC for 24 hours. 
The areas without bacteria around the copolymer films (inhibition zone) were 
recorded. 
 
3 Results and discussion 
3.1 Characterization of triblock copolymer diols 
The molecular weight and chemical structure of triblock copolymer diols were 
determined by 1H NMR analysis in CDCl3. As shown in Figure 1, the chemical shifts 
at 4.08 (HOCH2-) and 2.30 (-CH2COO-) correspond to the protons on the PCL units. 
The chemical shift at 3.64 (-OCH2CH2O-) can be assigned to the protons on the PEG 
units. Based on the intensity of peak a and b, the number of repeating units (n) of 
caprolactone and the molecular weight of the diols can be calculated [25] (Table 1, SI 
equation 1). The molecular weights and polydispersity (PDI) of the triblock 
100%b a
b
W W
W
−
= ×Weight loss(%)
copolymer diols were also determined by GPC (Table 1), with the molecular weights 
successfully tailored by adjusting the ratio of ε-CL to PEG400. The results indicate 
that the Mn(NMR) of the synthesized diols (see Figure 1) were close to the theoretical 
molecular weight while GPC analysis gave PDIs of 1.4 to 1.6.  
 
Figure 1 1H-NMR spectrum of the synthesized triblock copolymer diol (Pdiol2000) used to 
calculate the molecular weight of the polymer. 
 
Table 1 Molecular weight of triblock copolymer diols 
Triblock copolymer diols CL: PEG 
（mol:mol）  
Mn(NMR) GPC Yield(%) 
Mn Mw PDI 
Pdiol1000 5:1 869 1500 2100 1.42 83.3 
Pdiol2000 14:1 2053 3300 5500 1.66 85.3 
Pdiol3000 23:1 3162 5000 7600 1.54 82.9 
 
3.2 PUA oligomer characterization 
The molecular weights and polydispersity of the PUAs were determined by GPC 
(Table 2). The molecular weight of the PUAs ranged from 4000 to 14,000, increasing 
significantly as the molecular weight of the copolymer diols increased, with PDIs 
1.5-1.7. Since the stoichiometry of the monomers (HDI (or IPDI)): triblock copolymer 
diols: HEMA) was 2:1:2, the polymerization degree of the PUA was about 3, with a 
structure of HEMA-((HDI or IPDI)-PCEC)3-(HDI or IPDI)-HEMA. The oligomers 
were also analyzed with 1HNMR and FTIR (Fig. S1, S2) 
 
Table 2 Molecular weight and polydispersity of the PUAs 
PUAs Mn Mw PDI 
Pdiol1000-HDI 4090 6400 1.57 
Pdiol1000-IPDI 4100 6500 1.57 
Pdiol2000-HDI 8800 14700 1.67 
Pdiol2000-IPDI 8400 13100 1.56 
Pdiol3000-HDI 13500 21600 1.60 
Pdiol3000-IPDI 12400 21100 1.70 
 
3.3 Structure and morphology of cross-linked PUA films 
DSC was used to study the thermal behavior and microphase separation of the 
cross-linked PUA films and XRD was used to analyze the crystallinity of the 
polymers. The results suggest that Pdiol1000-HDI, Pdiol1000-IPDI and 
Pdiol2000-IPDI were all amorphous polymers with low glass transition temperatures 
and characteristic broad peaks, which agreed with literature [26] (Table 3, Fig. 2). 
XRD results of PUAs showed that Pdiol3000-HDI had sharp crystallization peaks 
with relatively high crystallinity 51 %, corresponding to the melting peak at about 40 
oC on the DSC curve. Pdiol2000-HDI and Pdiol3000-IPDI had only minor spikes on 
XRD indicating incomplete crystallization, which were consistent with the melting 
peaks and obvious glass transitions temperatures of amorphous parts in the polymer 
films on DSC curves. 
 
	
Figure 2 The morphology analysis of cross-linked PUA films: (a) DSC heating curves. Data 
were collected from the reheating run with scanning temperature from -75 to 120 oC with 10 
oC/min. (b) XRD spectra. The polymer films were cut into 10 mm × 10 mm samples for XRD 
measurement. The measurement was carried out under room temperature (20 oC) with the 
scanning angle (2θ) from 5 to 60° at a scan step of 0.02°. 
 
Pdiol2000-HDI, Pdiol3000-HDI and Pdiol3000-IPDI showed low Tg’s and Tm’s 
(Table 3). Additionally Pdiol2000-HDI and Pdiol3000-IPDI also exhibited cold 
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crystallization peaks. It has been reported that when the molecular weight is less than 
2000 g/mol, PCL is difficult to crystallize [27]. But the symmetrical structure of 
Pdiol2000-HDI changed this and improved the formation of the crystals. On the other 
hand, despite its long PCL segments, the reason of higher cold crystallization 
temperature (Tc=0 oC) of Pdiol3000-IPDI than the Pdiol2000-HDI was probably due 
to the IPDI, which acts as a hard segment with asymmetric structure to suppress the 
cold crystallization of PCL at lower temperature in the cross-linked PUA films.  
 
Table 3 Thermal properties of cross-linked PUA films 
Sample Tg(oC) Tm(oC) ΔH(J/g) Crystallinity（%） 
Pdiol1000-HDI -427 -- -- -- 
Pdiol1000-IPDI -30.1 -- -- -- 
Pdiol2000-HDI -57.1 21.5 5.1 6.6 
Pdiol2000-IPDI -51.2 -- -- -- 
Pdiol3000-HDI -55.2 40.0 43.4 50.9 
Pdiol3000-IPDI -57.5 30.8 21.7 25.5 
 
Microphase separation that occurred due to crystallization in the cross-linked PUA 
films could be detected using DMA (Fig. 3 and Table 4). The storage modulus of the 
Pdiol3000-HDI showed larger storage modulus than that of Pdiol1000-HDI (which 
had the second highest overall crosslink density compared to the other samples) due 
to the highest crystallinity (50.9 %, Table 3) among all of the polymers. In the same 
reason the Pdiol3000-IPDI showed also higher storage modulus than the amorphous 
Pdiol2000-IPDI.  
The Pdiol3000-HDI and -IPDI showed broad peaks on tanδ curves indicating there 
were at least two steps of chain relaxation [26], including relaxation of soft and hard 
segments respectively (Fig. 3b, d). The peaks at low temperature showed glass 
transition of the soft parts on the polymer chains, corresponding to the first step 
decreasing of the storage modulus. While those peaks at the higher temperature were 
glass transitions of hard segments including urethane acrylate and the melting of the 
small crystals, corresponding to the second step of the storage modulus reduction. 
Other polymers did not show the similar obvious broad peaks on tanδ curves because 
of either high crosslink density or low crystallinity. However, the trend of the Tg of 
the polymers is increasing with the crosslinking density and the Tg was normally 
higher when IPDI was used.	
	
Figure 3 Dynamic mechanical temperature sweep curves of cross-linked PUA films at single 
frequencies of 1Hz with the temperatures scanned from −100 to 150 °C with a heating rate of 4 
oC/min and 0.04 % strain. (a, c) Storage modulus and (b, d) loss factor (tan Delta). 
 
Table 4 Tg, modulus and cross-link density of cross-linked  
PUA copolymers based on DMA measurements 
Sample Tg(oC) ×106 (N/m2)  (mol/m3) 
Pdiol1000-HDI -14.0 4.5 555.3 
Pdiol1000-IPDI 28.3 10.8 1338.1 
Pdiol2000-HDI -51.6 1.3 159.0 
Pdiol2000-IPDI -56.5 1.6 200.1 
Pdiol3000-HDI -45.1/-14.1 0.6 73.7 
Pdiol3000-IPDI -40.6/24.4 1.1 138.9 
Notes: Average molecular weight between cross-linking sites, ; Cross-link 
density of cross-linked PUA polymers, , therefore , here T and R 
are respectively 323K and 8.314 m3Pa/mol K. 
	
3.4 Hydrophilicity of polymers 
Polymer hydrophilicity is an important factor that affects the polymer degradation and 
drug delivery properties. Contact angle and swelling are measurements of the 
hydrophilicty of a surface and the bulk properties of the polymer.  
Results indicate that a higher molecular weight of PCL lead to more hydrophobic 
cross-linked PUA films with larger contact angles (Table 5). The Pdiol1000-HDI was 
the most hydrophilic material among all the polymers with instant contact angles 
greater than the corresponding dynamic contact angles (measured after dropping 
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water on the surface for 5 min) due to the diffusion of the water along the polarized 
part of the polyurethane chains, which causes the surface rearrangement of the 
cross-linked PUA [28]. 
Table 5 Water contact angles of the cross-linked PUAs 
(Standard deviation errors, n=4) 
Sample 5s 5min 
Pdiol1000-HDI 63.3±5.1 35±2.6 
Pdiol1000-IPDI 74.5±3.8 56.7±0.8 
Pdiol2000-HDI 76.0±3.7 58.0±3.0 
Pdiol2000-IPDI 75.5±3.9 57.2±4.5 
Pdiol3000-HDI 77.5±1.7 60.5±2.6 
Pdiol3000-IPDI 78.8±2.1 67.2±2.9 
 
Swelling of the cross-linked PUA films as a result of solvent uptake in water and THF 
showed that the Pdiol1000-HDI had the highest water uptake of 9 % after 72 h, which 
was consistent with the water contact angle results which showed it to be the most 
hydrophilic polymer (Fig 4). Water uptake reduced with the increase in molecular 
weight of PCL because of its hydrophobic nature. However, the water uptake 
increased with longer soaking time in water for all the polymers (Fig 4a).  
6 24 48 72
0
4
8
12
Sw
el
lin
g 
in
 w
at
er
 (%
)
 Pdiol1000-HDI
 Pdiol1000-IPDI
 Pdiol2000-HDI
 Pdiol2000-IPDI
 Pdiol3000-HDI
 Pdiol3000-IPDI
a
t (h)
	
	
6 24
0
100
200
300
400
500
Sw
el
lin
g 
in
 T
H
F 
(%
)
t (h)
 Pdiol1000-HDI
 Pdiol1000-IPDI
 Pdiol2000-HDI
 Pdiol2000-IPDI
 Pdiol3000-HDI
 Pdiol3000-IPDI
b
	
	
	
Figure 4 Swelling of cross-linked PUA films. （a）Swelling of cross-linked PUA films in water; 
（b）Swelling of cross-linked PUA films in THF.  Errors are standard deviation, n=3. 
 
The swelling in THF of the cross-linked PUA films were also measured (Fig 4b) 
at the time points of 6 and 24 h respectively. It showed that most of the polymers had 
reached a saturated swelling state after 6 h. The highest swelling ratio among all 
polymers was Pdiol3000-HDI reaching 465 % swelling in 24 h. However, 
Pdiol3000-IPDI showed only a swelling of 360 %. The reason might be the ring 
structure of the IPDI increased the cross-link density after polymerization (Table 3) 
that suppressed the swelling of the polymer. 
 
3.5 In vitro degradation  
The biodegradation of cross-linked PUA films was investigated under different 
conditions including lipases and oxidative milieu as both, esterases and peroxides (Fig. 
5), play important roles for biodegradation in in vivo systems [29]. 
	
Figure 5 Degradation profiles of cross-linked PUA films in degradation solutions. (a) Hydrolytic 
degradation of polymers in PBS solution (pH=7.4); (b) Enzymatic degradation of polymers in 
lipase solution; (c) Oxidative degradation of polymers in H2O2 solution. Error bars represent mean 
standard deviations, n = 4. 
 
The results of weight loss experiments indicate that the cross-linked PUAs degraded 
much more rapidly in H2O2 solution than the others (Fig 5c). Pdiol1000-HDI 
degraded fully after 7 weeks. Even the most hydrophobic Pdiol3000-IPDI degraded 
over 30% in 11 weeks. This means that these kinds of polymers were vulnerable to 
attacked by these free radicals. Christenson [30-31] proposed that the oxidative 
degradation of polyester urethanes is similar to that of polyether urethanes. The 
hydrogen peroxide produces hydroxyl and hydroperoxy radicals in water, via CoCl2 
mediated catalysis, attacking the hydrogen of the α-methylene group, leading to chain 
scission [24]. Lipase accelerated degradation of hydrophilic polymers was (as 
expected) more prominent than with hydrophobic ones (Fig. 5b), as enzymatic 
degradation happens mainly around water soluble domains on the polymer chains，
such as found in Pdiol1000-HDI which lost about 45% by mass in 11 weeks (Fig. 5a). 
The degradation of hydrophobic polymers catalyzed by lipases was less significant. 
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Upon oxidative degradation in H2O2 solution for 5 weeks, the transparent cross-linked 
PUA films of Pdiol1000-HDI, Pdiol1000-IPDI and Pdiol2000-IPDI were observed to 
become rough, opaque and with cracks (Fig. S3). Especially Pdiol1000-HDI, which 
lost a large part of its weight and shrunk significantly. Surface damage was also 
discerned when they degraded in PBS and lipase solutions for the same period of time, 
showing stress lines and roughness on the surfaces, The opaque films of 
Pdiol3000-HDI and –IPDI however showed almost no change (via the naked eye). 
SEM images showed the porous type of character of the Pdiol1000-HDI polymer film 
after degradation in H2O2 solution (Fig. 6a, b).  
 
Figure 6 SEM images of the cross-linked PUA membranes before and after degradation 
experiments in PBS, PBS/lipase and PBS/H2O2/CoCl2 solutions for 5 weeks. (a) Pdiol1000-HDI 
before degradation; (b) Pdiol1000-HDI after degradation in PBS/H2O2/CoCl2 solution; (c) 
Diol2000-HDI before degradation; (d) Pdiol2000-HDI after degradation in PBS; (e) 
Pdiol2000-IPDI before degradation; (f) Pdiol2000-IPDI after degradation in lipase solution; (g) 
Pdiol2000-IPDI after degradation in PBS/H2O2/CoCl2 solution; (h) Pdiol3000-HDI before 
degradation; (i) Pdiol3000-HDI after degradation in PBS; (j) Pdiol3000-HDI after degradation in 
PBS/H2O2/CoCl2 solutions; (k) Pdiol3000-IPDI before degradation; (l) Pdiol3000-IPDI after 
degradation in PBS/H2O2/CoCl2 solution. Scale bars in all SEM images are 10µm. 
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3.6 Drug release from cross-linked PUAs as long-term antibacteria releasing film 
The drug was loaded onto cross-linked PUA films (10 mm × 10 mm× 0.5 mm) by 
immersing films in THF with tetracycline (1 wt%) for 12 h followed by removal of 
the solvent in vacuum at 50 °C. THF was used as it swells the polymer and dissolves 
the drug. The drug loading capacity of the polymer films was determined by washing 
the drug out of the films with THF (Table 6) showed that Pdiol3000-IPDI had the 
highest drug loading, while Pdiol1000-IPDI had the lowest. 
 
Table 6 The drug loading capacity on cross-linked PUA films (n=4) 
Sample Loading capacity (µg/mL) 
Pdiol1000-HDI 20.5±1.4 
Pdiol1000-IPDI 14.0±2.9 
Pdiol2000-HDI 25.7±0.4 
Pdiol2000-IPDI 24.9±1.5 
Pdiol3000-HDI 36.7±12.4 
Pdiol3000-IPDI 43.6±5.5 
  
The drug release profile of the cross-linked PUA films were carried out in PBS and 
cumulative release percentage is presented in Fig. 7. It was found that Pdiol2000-IPDI 
and Pdiol3000-HDI exhibited high levels of drug release, releasing 87 % and 58 % of 
the loaded drug respectively after 250 h. Pdiol3000-IPDI released 38 % of the loaded 
drug after 300 h and Pdiol1000-HDI released 35 %, while Pdiol1000-IPDI and 
Pdiol2000-HDI released only 14 % and 8 % of the loaded drug even after 300 h.  
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Figure 7 Drug releasing profile of cross-linked PUA films loaded with tetracycline in PBS. 
Errors are STDEV, n=3. 
All polymers swelled to approximately the same level in water (see Fig. 4), likewise within 800 
hours (approx. 5 weeks) there was still only limited degradation (≈5 % in PBS, see Fig. 5) 
suggesting that drug release is dominated by drug-polymer interactions. Thus more of the drug 
will stay entrapped within the hydrophilic polymers (e.g. Pdiol1000) via H-bonding (tetracycline 
has a logp of -1.30).  With the two polymers Pdiol2000IPDI and the Pdiol3000HDI (that show 
greatest release) we believe that interactions to trap the hydrophilic drug within the more 
hydrophobic environment are reduced, thus leading to enhanced drug release. 
The tetracycline loaded cross-linked PUA films were applied to lawns of bacteria to test their 
anti-bacteria capacity (10 mm × 10 mm), releasing drug which diffused into the gel and 
prevented bacterial growth (Fig. 8). This zone diffusion antibiotic assay was used to augment the 
tetracycline release assays to prove that the drug released was active (non-degraded) and capable 
of killing bacteria at the released dose. It was also used to show that the control polymer was 
non-antibacterial in nature.  
 
 
Figure 8 Images of inhibition zones of tetracycline loaded crosslinked PUA films incubated on 
lawns of bacteria for 24 h. (a) Pdiol1000-HDI without drug; (b) Pdiol1000-HDI with drug; (c) 
Pdiol1000-IPDI without drug; (d) Pdiol1000-IPDI with drug; (e) Pdiol2000-HDI without drug; (f) 
Pdiol2000-HDI with drug; (g) Pdiol2000-IPDI without drug; (h) Pdiol2000-IPDI with drug; (i) 
Pdiol3000-HDI without drug; (j) Pdiol3000-HDI with drug; (k) Pdiol3000-IPDI without drug; (l) 
Pdiol3000-IPDI with drug. 
 
4. Conclusion 
In this study, PCL-PEG-PCL triblock copolymer diols with various molecular weights 
were successfully synthesized by changing the PEG400/ε-CL ratio, and the PUA 
oligomers were obtained by reacting copolymer diols with HDI/IPDI and then 
end-capped with HEMA. After UV-curing, cross-linked PUAs were prepared. By 
increasing the molecular weight of PCL segments (in copolymer diols), the 
crystallinity of the cross-linked PUA films increased and their swelling in water 
reduced. Experiments showed that the cross-linked PUA films degraded most rapidly 
in H2O2 solution. In the lipase solution, only the hydrophilic polymer films showed 
greater degradation than in PBS solutions. Degradation rates were also influenced by 
the structure of the polymer. Pdiol1000-HDI films showed the fastest degradation 
rates among all of the polymers in H2O2 solutions due to their excellent hydrophilicity, 
amorphous state and reduced cross-link densities. The cross-linked PUA films loaded 
with antibiotic drug tetracycline showed sustained drug release. This work 
demonstrates that these antibiotic loaded polymer films have the potential to be 
applied in medical devices such as in-dwelling catheters which are a major source of 
hospital infections, as well as coatings for other types of implants (e.g. metal-based 
implants) that can also result in chronic infections. Typically in these scenarios drugs 
need to be released in a sustained manner due continual bacterial insult and as such 
the materials we have designed, that allow controlled and long term drug release 
would find useful application. 
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